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The very high levels of 5-hydroxymethylcytosine (5hmC)
present in neuronal genomes and its accumulation within
gene bodies suggests that the epigenetic mechanisms
interpreting 5hmC in the central nervous system (CNS)
may differ from those present in embryonic stem (ES)
cells. Here we present the first quantitative, genome-wide
analysis of 5hmC, 5-methylcytosine (5mC) and gene
expression in identified, terminally differentiated CNS cell
types in vivo. We report that the high level of 5hmC pre-
sent in neurons is enriched in active transcription units,
and that surprisingly strong depletion of 5mC over gene
bodies is observed for these genes. However, the relative
contribution of these epigenetic marks to gene expression
depends critically on cell type. We identify methyl-CpG
binding protein 2 (MeCP2) as the major 5hmC binding
protein in the brain, and demonstrate that MeCP2 binds
5hmC and 5mC containing DNA with similar high affi-
nities. The Rett Syndrome causing mutation of residue
R133C in the MeCP2 methyl-CpG binding domain (MBD)
preferentially inhibit 5hmC binding. Loss of MeCP2 does
not alter the genomic distribution of 5hmC. These find-
ings demonstrate that 5hmC and MeCP2 constitute a
novel, cell specific epigenetic mechanism for regulation of
chromatin structure and gene expression in the mamma-
lian nervous system, and they provide new mechanistic
insights into the pathophysiology of Rett Syndrome (RTT).
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